Product
Inactivated COVID-19 Vaccine
Aliases
CoronaVac
3 clinical trials
1 indication
Indication
COVID-19Clinical trial
Immunogenicity of an Inactivated COVID-19 Vaccine for Prevention of COVID-19 in Population Aged 3-11 YearsStatus: Completed, Estimated PCD: 2022-01-24
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of COVID-19 Vaccine(Vero Cell) ,Inactivated in Children and Adolescents Aged 6 Months to 17 YearsStatus: Completed, Estimated PCD: 2023-05-31
Clinical trial
Immunogenicity,Safety and Cross - Immune Response With Mutant Strains of the Third Dose Using Inactivated COVID-19 Vaccine in Population Aged 18 Years and AboveStatus: Active (not recruiting), Estimated PCD: 2022-06-19